U.S. Markets closed
  • S&P 500

    -18.19 (-0.48%)
  • Dow 30

    -469.64 (-1.50%)
  • Nasdaq

    +72.92 (+0.56%)
  • Russell 2000

    +0.88 (+0.04%)
  • Crude Oil

    -1.87 (-2.94%)
  • Gold

    -42.40 (-2.39%)
  • Silver

    -0.98 (-3.56%)

    -0.0099 (-0.8099%)
  • 10-Yr Bond

    -0.0580 (-3.82%)
  • Vix

    -0.94 (-3.25%)

    -0.0091 (-0.6460%)

    +0.3200 (+0.3012%)

    -3,024.98 (-6.38%)
  • CMC Crypto 200

    -20.25 (-2.17%)
  • FTSE 100

    -168.53 (-2.53%)
  • Nikkei 225

    -1,202.26 (-3.99%)

NextGen's (NXGN) HDH to Facilitate Health Information Exchange

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·3 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

NextGen Healthcare, Inc. NXGN recently announced that its NextGen Health Data Hub (HDH) has been chosen by HI-BRIDGE HIE (health information exchange). This will enable HIE administrators to build rules-driven data exchange to facilitate automated routing of patient information across the group of care.

Notably, NextGen HDH is a cloud-based HIE platform that lends support to secure sharing of patient health data from numerous sources.

This deal is likely to provide a boost to NextGen’s robust solutions portfolio.

More on the News

NextGen HDH is an advanced solution offering built-in patient matching, an API-first design, a provider portal and support for behavioral health data protection. HDH provides support to all the clinical data types that are utilized by in-patient and ambulatory health systems. Moreover, the solution’s solid data normalization abilities allow all connected systems to interoperate successfully.

With this collaboration, NextGen will be part of and support the future data exchange in the greater Atlanta region. Further, the company remains confident that the choice of HDH can bolster greater interoperability, data access and clinical insights for all connected providers.

Market Prospects

Per a Medgadget report, the global health information exchange market was worth $1.19 billion in 2018 and is anticipated to reach $2.18 billion by 2025, witnessing a CAGR of 8.9% over the forecast period. Hence, this announcement is a well-timed one for NextGen.

Recent Developments

This month, NextGen announced that its client — Bridges Health Partners LLC — has managed to boost quality of patient care and attain value-based care financial goals throughout its wide network of 1,100 physicians with the aid of NextGen Population Health. Additionally, Bridges Health has exceeded its savings objectives (nearly $20 million) for two consecutive years.

In November, the company announced that NextGen Enterprise has been chosen by Orthopaedic & Sports Medicine Center (OSMC) as its core electronic health record (EHR) and practice management (PM) solution. Notably, OSMC is a premier orthopedic center in the northeast region of Kansas. Being a fully integrated, single database platform, NextGen Enterprise with Orthopedic Suite provides intuitive clinical workflows created for complicated orthopedic organizations, which offer patients a consolidated, non-surgical and rehabilitation experience.

Price Performance

Shares of this Zacks Rank #3 (Hold) company have gained 19.4% in a year’s time, compared with the industry’s rally of 32.4%.

Stocks to Consider

Some better-ranked stocks from the broader medical space are Merit Medical Systems, Inc. MMSI, Align Technology, Inc. ALGN and Thermo Fisher Scientific Inc. TMO, each carrying a Zacks Rank #2 (Buy) at present. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Merit Medical has a projected long-term earnings growth rate of 12.6%.

Align Technology has an estimated long-term earnings growth rate of 18.3%.

Thermo Fisher has a projected long-term earnings growth rate of 18%.

Legal Marijuana: An Investor’s Dream

Imagine getting in early on a young industry primed to skyrocket from $17.7 billion in 2019 to an expected $73.6 billion by 2027.

Although marijuana stocks did better as the pandemic took hold than the market as a whole, they’ve been pushed down. This is exactly the right time to get in on selected strong companies at a fraction of their value before COVID struck. Zacks’ Special Report, Marijuana Moneymakers, reveals 10 exciting tickers for urgent consideration.

Download Marijuana Moneymakers FREE >>

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Merit Medical Systems, Inc. (MMSI) : Free Stock Analysis Report
Align Technology, Inc. (ALGN) : Free Stock Analysis Report
Thermo Fisher Scientific Inc. (TMO) : Free Stock Analysis Report
NEXTGEN HEALTHCARE, INC (NXGN) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research